For example, a tumor sample with VAF of 28% for a pathogenic mutation identified in the TP53 gene (p.Gly279Glu) coexisting with uncertain significance in PIK3CA (VAF of 3%) and APC (VAF of 5%) genes. This evidence concerns the gene TP53 and neoplasm.